• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Enhancing collaboration between academia and industry in kidney disease research.

作者信息

Unwin Robert J, Challis Benjamin, MacPhee Iain, Hansen Pernille B L, Jones Rachel, Salama Alan, Barratt Jonathan

机构信息

AstraZeneca Biopharmaceuticals R&D, Early Cardiovascular, Renal and Metabolism (CVRM), Cambridge, UK and Gothenburg, Sweden.

UCL Centre for Kidney and Bladder Health, University College London, London, UK.

出版信息

Nephrol Dial Transplant. 2025 Apr 28;40(5):836-838. doi: 10.1093/ndt/gfae272.

DOI:10.1093/ndt/gfae272
PMID:39611334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12209843/
Abstract
摘要

相似文献

1
Enhancing collaboration between academia and industry in kidney disease research.加强学术界与产业界在肾脏疾病研究方面的合作。
Nephrol Dial Transplant. 2025 Apr 28;40(5):836-838. doi: 10.1093/ndt/gfae272.
2
Provenance and Clinical Benefit of Medicines Introduced to the French Market, 2008 to 2018.2008 年至 2018 年法国上市药品的来源和临床获益。
JAMA Intern Med. 2024 Jan 1;184(1):46-52. doi: 10.1001/jamainternmed.2023.6249.
3
A systematic review of mHealth application interventions for peripartum mood disorders: trends and evidence in academia and industry.一项针对围产期情绪障碍的移动医疗应用干预措施的系统评价：学术界和产业界的趋势和证据。
Arch Womens Ment Health. 2021 Dec;24(6):881-892. doi: 10.1007/s00737-021-01138-z. Epub 2021 Apr 30.
4
Measuring co-constructive collaboration between general and special education teachers in inclusive schools-development and validation of two short questionnaires.测量融合学校中普通教育教师与特殊教育教师之间的协同合作——两份简短问卷的编制与验证
Front Psychol. 2025 Jun 17;16:1535727. doi: 10.3389/fpsyg.2025.1535727. eCollection 2025.
5
Assessing Renal Function in Chronic Kidney Disease: A Comparative Evaluation of Glomerular Filtration Rate Prediction Equations in the North-Central Region of Nigeria.评估慢性肾脏病患者的肾功能：尼日利亚中北部地区肾小球滤过率预测方程的比较评价
Cureus. 2025 May 21;17(5):e84577. doi: 10.7759/cureus.84577. eCollection 2025 May.
6
Comparing interprofessional and interorganizational collaboration in healthcare: A systematic review of the qualitative research.比较医疗保健中的跨专业和跨组织合作：定性研究的系统评价。
Int J Nurs Stud. 2018 Mar;79:70-83. doi: 10.1016/j.ijnurstu.2017.11.002. Epub 2017 Nov 11.
7
Modelling outbreak response impact in human vaccine-preventable diseases: A systematic review of differences in practices between collaboration types before COVID-19.建模人类疫苗可预防疾病爆发应对效果：COVID-19 之前不同合作类型实践差异的系统综述。
Epidemics. 2023 Dec;45:100720. doi: 10.1016/j.epidem.2023.100720. Epub 2023 Oct 30.
8
Advancing stroke rehabilitation: the role of wearable technology according to research experts.推进中风康复：根据研究专家的观点看可穿戴技术的作用。
Disabil Rehabil Assist Technol. 2025 Jul;20(5):1460-1469. doi: 10.1080/17483107.2025.2459326. Epub 2025 Jan 28.
9
[Academia-Industry Alliance: Recent Trend].[学术界-产业界联盟：近期趋势]
No Shinkei Geka. 2024 Jan;52(1):213-225. doi: 10.11477/mf.1436204899.
10
A Model for an Academia-Industry Collaboration for Pharmacovigilance and Pharmacoepidemiology.药物警戒与药物流行病学的产学研合作模式
Pharmaceut Med. 2025 May;39(3):151-156. doi: 10.1007/s40290-025-00567-w. Epub 2025 May 23.

本文引用的文献

1
Clinical Trials for Kidney Disease in the Era of Personalized Medicine.个性化医疗时代的肾脏疾病临床试验
J Am Soc Nephrol. 2024 Aug 1;35(8):1123-1126. doi: 10.1681/ASN.0000000000000412. Epub 2024 May 9.
2
The benefits of GLP-1 drugs beyond obesity.胰高血糖素样肽-1（GLP-1）药物在治疗肥胖症之外的益处。
Science. 2024 Jul 19;385(6706):258-260. doi: 10.1126/science.adn4128. Epub 2024 Jul 18.
3
Associations with age and glomerular filtration rate in a referred population with chronic kidney disease: methods and baseline data from a UK multicentre cohort study (NURTuRE-CKD).在一个有慢性肾脏病的转诊人群中，年龄和肾小球滤过率的关系：来自英国多中心队列研究（NURTuRE-CKD）的方法和基线数据。
Nephrol Dial Transplant. 2023 Oct 31;38(11):2617-2626. doi: 10.1093/ndt/gfad110.
4
Selecting the right therapeutic target for kidney disease.为肾病选择合适的治疗靶点。
Front Pharmacol. 2022 Nov 2;13:971065. doi: 10.3389/fphar.2022.971065. eCollection 2022.
5
Kidney-Protective Effects of SGLT2 Inhibitors.SGLT2 抑制剂的肾脏保护作用。
Clin J Am Soc Nephrol. 2023 Feb 1;18(2):279-289. doi: 10.2215/CJN.09380822. Epub 2022 Oct 20.
6
2021 FDA approvals.2021年美国食品药品监督管理局的批准情况。
Nat Rev Drug Discov. 2022 Feb;21(2):83-88. doi: 10.1038/d41573-022-00001-9.
7
IgA Vasculitis and IgA Nephropathy: Same Disease?IgA血管炎与IgA肾病：是同一种疾病吗？
J Clin Med. 2021 May 25;10(11):2310. doi: 10.3390/jcm10112310.
8
Deep Learning-Based Segmentation and Quantification in Experimental Kidney Histopathology.基于深度学习的实验性肾脏组织病理学分割与定量分析。
J Am Soc Nephrol. 2021 Jan;32(1):52-68. doi: 10.1681/ASN.2020050597. Epub 2020 Nov 5.
9
Integrated multi-omics approaches to improve classification of chronic kidney disease.综合多组学方法提高慢性肾脏病的分类。
Nat Rev Nephrol. 2020 Nov;16(11):657-668. doi: 10.1038/s41581-020-0286-5. Epub 2020 May 18.